Mason Stephen M
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Mason Stephen M. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CAH | CEO, GMPD Segment | Tax Withholding | 595 | $212.26 | $126,295 | Dec 1, 2025 |
| CAH | CEO, GMPD Segment | Sale | 4,167 | $149.39 | $622,508 | Aug 15, 2025 |
| CAH | CEO, GMPD Segment | Award / Grant | 54,537 | — | — | Aug 12, 2025 |
| CAH | CEO, GMPD Segment | Tax Withholding | 5,694 | $167.18 | $951,923 | Jun 30, 2025 |
| CAH | CEO, GMPD Segment | Option Exercise | 5,990 | $84.27 | $504,777 | Aug 15, 2024 |
| CAH | CEO, GMPD Segment | Award / Grant | 45,958 | — | — | Aug 13, 2024 |
| CAH | CEO, Medical Segment | Sale | 10,995 | $86.40 | $949,968 | Aug 16, 2023 |
| CAH | CEO, Medical Segment | Award / Grant | 38,282 | — | — | Aug 7, 2023 |
| CAH | CEO, Medical Segment | Sale | 61,216 | $80.87 | $4,950,538 | Nov 7, 2022 |
| CAH | CEO, Medical Segment | Award / Grant | 17,150 | — | — | Aug 15, 2022 |
| CAH | CEO, Medical Segment | Award / Grant | 29,893 | — | — | Aug 9, 2022 |
| CAH | CEO, Medical Segment | Award / Grant | 21,277 | — | — | Aug 15, 2021 |
| CAH | CEO, Medical Segment | Award / Grant | 7,209 | — | — | Aug 3, 2021 |
| CAH | CEO, Medical Segment | Award / Grant | 18,629 | — | — | Aug 15, 2020 |
| CAH | CEO, Medical Segment | Award / Grant | 429 | — | — | Aug 3, 2020 |